Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients - Concepedia

Concepedia

Publication | Open Access

Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients

DOI Full Paper Access

58

Citations

21

References

2013

Year

Andrew Weickhardt, Robert C. Doebele, W. Thomas Purcell, Paul A. Bunn, Ana B. Oton, Micol S. Rothman, Margaret E. Wierman, Tony Mok, Sanjay Popat, Julie E. Bauman,

Abstract

Symptoms of androgen deficiency and free or total/free testosterone levels should be tracked in male patients on crizotinib with consideration of testosterone replacement as appropriate.

References

	Year	Citations

Page 1